Lv5
940 积分 2021-07-07 加入
Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies
2天前
已完结
Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
2天前
已完结
Controlled withdrawal of pramipexole after 6 months of open‐label treatment in patients with restless legs syndrome
2天前
已完结
Efficacy and safety of pramipexole in restless legs syndrome
3天前
已完结
Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study
3天前
已完结
Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: Results from a multi-center, randomized, double-blind, placebo-controlled trial
3天前
已完结
Long‐term treatment with pramipexole in restless legs syndrome
3天前
已完结
Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease
5天前
已完结
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
7天前
已完结
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease
7天前
已完结
Pathophysiology of Paroxysmal Dyskinesia
皖公网安备34019202002308
